These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31015575)

  • 1. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; Chung WK; Kearney HM; Monaghan KG; Rehder CW; Chao EC;
    Genet Med; 2019 Jun; 21(6):1267-1270. PubMed ID: 31015575
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
    David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
    Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
    Bush LW; Bartoshesky LE; David KL; Wilfond B; Williams JL; Holm IA;
    Genet Med; 2018 Jul; 20(7):692-694. PubMed ID: 29565417
    [No Abstract]   [Full Text] [Related]  

  • 4. Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Gordon AS; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Harrison SM; Hershberger RE; Richards CS; Stewart DR; Martin CL; Miller DT;
    Genet Med; 2024 Jul; 26(7):101142. PubMed ID: 38819344
    [No Abstract]   [Full Text] [Related]  

  • 5. Professional responsibilities regarding the provision, publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
    Bush LW; Beck AE; Biesecker LG; Evans JP; Hamosh A; Holm IA; Martin CL; Richards CS; Rehm HL
    Genet Med; 2018 Feb; 20(2):169-171. PubMed ID: 29323668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
    [No Abstract]   [Full Text] [Related]  

  • 7. Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2015 Sep; 17(9):e3. PubMed ID: 26204421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American College of Medical Genetics and Genomics: revised scope of practice and strategic plan.
    Feldman G
    Genet Med; 2015 Sep; 17(9):713. PubMed ID: 26204422
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on "Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)" by Grebe et al.
    Widen E; Lello L; Eccles J; Marin D; Treff NR
    Genet Med; 2024 Aug; 26(8):101155. PubMed ID: 38856723
    [No Abstract]   [Full Text] [Related]  

  • 10. American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing.
    Rehder CW; David KL; Hirsch B; Toriello HV; Wilson CM; Kearney HM
    Genet Med; 2013 Feb; 15(2):150-2. PubMed ID: 23328890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
    Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
    Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome editing in clinical genetics: points to consider-a statement of the American College of Medical Genetics and Genomics.
    Acmg Board Of Directors
    Genet Med; 2017 Jul; 19(7):723-724. PubMed ID: 28125080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Points to consider for providing expert witness testimony for the specialty of medical genetics: A statement of the American College of Medical Genetics and Genomics (ACMG).
    Seaver LH; Chan P; Fleisher LD; Huang SJ; Klugman SD; Matalon DR;
    Genet Med; 2024 Oct; 26(10):101229. PubMed ID: 39240268
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).
    Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G;
    Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Gallagher RC; Pollard L; Scott AI; Huguenin S; Goodman S; Sun Q;
    Genet Med; 2018 Jul; 20(7):683-691. PubMed ID: 29543224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
    Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
    Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory testing for preconception/prenatal carrier screening: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Guha S; Reddi HV; Aarabi M; DiStefano M; Wakeling E; Dungan JS; Gregg AR;
    Genet Med; 2024 Jul; 26(7):101137. PubMed ID: 38814327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).
    Bean LJH; Scheuner MT; Murray MF; Biesecker LG; Green RC; Monaghan KG; Palomaki GE; Sharp RR; Trotter TL; Watson MS; Powell CM;
    Genet Med; 2021 Jun; 23(6):979-988. PubMed ID: 33790423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.